RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Kyorin Pharmaceutical Co Stock

Kyorin Pharmaceutical Co ROCE 2024

Kyorin Pharmaceutical Co ROCE

0.05

Ticker

4569.T

ISIN

JP3247090008

In 2024, Kyorin Pharmaceutical Co's return on capital employed (ROCE) was 0.05, a 14.27% increase from the 0.04 ROCE in the previous year.

Kyorin Pharmaceutical Co Aktienanalyse

What does Kyorin Pharmaceutical Co do?

Kyorin Holdings Inc is a Japanese holding company that was founded in September 2007. However, the company's history dates back to 1947 when Kyorin Pharmaceutical Co., Ltd. was established. Kyorin Holdings is a diversified company that operates in various sectors and business areas. The company's main activities include the development, production, and marketing of pharmaceutical products, medical devices, and healthcare products. In the pharmaceutical sector, Kyorin has been active since its inception. The company offers a wide range of products for various conditions such as asthma, allergies, or diabetes. Additionally, Kyorin is dedicated to developing medications for rarer diseases such as Fabry disease or amyotrophic lateral sclerosis (ALS). Another important business area of Kyorin is medical devices and accessories. The company primarily focuses on devices for the diagnosis and treatment of respiratory diseases and allergies. This includes inhalers, peak flow meters, and allergy tests. Healthcare is another significant business area of Kyorin Holdings. The company offers products for maintaining and strengthening the immune system, such as dietary supplements and probiotics. Kyorin also provides cosmetic products made from plant-based ingredients. One of Kyorin's current projects is the development of peptide-based immunotherapies for cancer. The company has already achieved promising results in preclinical research and plans to continue clinical trials in the coming years. The corporate philosophy of Kyorin emphasizes the importance of research and development. The company invests a significant portion of its annual revenue in research and development and strives to find innovative solutions for disease treatment. Kyorin also values collaboration with other companies and research institutions. The company has formed partnerships with other pharmaceutical and medical technology companies to work together on the research and development of new products. Kyorin Holdings Inc is a company that focuses on the development and marketing of products that contribute to improving health and well-being. The company's various business areas allow it to target different audiences and meet the needs of patients and customers in various fields. With its long-standing experience in the pharmaceutical and medical technology sectors and its commitment to innovation and research, Kyorin remains an important player in healthcare and is dedicated to improving the quality of life for people worldwide. Kyorin Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Kyorin Pharmaceutical Co's Return on Capital Employed (ROCE)

Kyorin Pharmaceutical Co's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Kyorin Pharmaceutical Co's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Kyorin Pharmaceutical Co's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Kyorin Pharmaceutical Co’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Kyorin Pharmaceutical Co stock

What is the ROCE (Return on Capital Employed) of Kyorin Pharmaceutical Co this year?

The ROCE of Kyorin Pharmaceutical Co is 0.05 undefined this year.

How has the ROCE (Return on Capital Employed) of Kyorin Pharmaceutical Co developed compared to the previous year?

The ROCE of Kyorin Pharmaceutical Co has increased by 14.27% increased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Kyorin Pharmaceutical Co?

A high Return on Capital Employed (ROCE) indicates that Kyorin Pharmaceutical Co has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Kyorin Pharmaceutical Co?

A low ROCE (Return on Capital Employed) can indicate that Kyorin Pharmaceutical Co has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Kyorin Pharmaceutical Co impact the company?

An increase in the ROCE of Kyorin Pharmaceutical Co can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Kyorin Pharmaceutical Co affect the company?

A decrease in ROCE of Kyorin Pharmaceutical Co can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Kyorin Pharmaceutical Co?

Some factors that can affect Kyorin Pharmaceutical Co's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Kyorin Pharmaceutical Co so important for investors?

The ROCE of Kyorin Pharmaceutical Co is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Kyorin Pharmaceutical Co take to improve the ROCE?

To improve the ROCE, Kyorin Pharmaceutical Co can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Kyorin Pharmaceutical Co pay?

Over the past 12 months, Kyorin Pharmaceutical Co paid a dividend of 52 JPY . This corresponds to a dividend yield of about 3.26 %. For the coming 12 months, Kyorin Pharmaceutical Co is expected to pay a dividend of 52.48 JPY.

What is the dividend yield of Kyorin Pharmaceutical Co?

The current dividend yield of Kyorin Pharmaceutical Co is 3.26 %.

When does Kyorin Pharmaceutical Co pay dividends?

Kyorin Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Kyorin Pharmaceutical Co?

Kyorin Pharmaceutical Co paid dividends every year for the past 22 years.

What is the dividend of Kyorin Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 52.48 JPY are expected. This corresponds to a dividend yield of 3.29 %.

In which sector is Kyorin Pharmaceutical Co located?

Kyorin Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Kyorin Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Kyorin Pharmaceutical Co from 12/1/2024 amounting to 20 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Kyorin Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 12/1/2024.

What was the dividend of Kyorin Pharmaceutical Co in the year 2023?

In the year 2023, Kyorin Pharmaceutical Co distributed 52 JPY as dividends.

In which currency does Kyorin Pharmaceutical Co pay out the dividend?

The dividends of Kyorin Pharmaceutical Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Kyorin Pharmaceutical Co

Our stock analysis for Kyorin Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kyorin Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.